Director and Chief Executive Officer
Peter holds a Bachelors degree in Science (Combined honours in Zoology and Physiology) from University of Sheffield, United Kingdom and has almost three decades of experience in the global pharmaceutical space. He is responsible for the daily operations and takes strategic decisions. Before his appointment to the Board, he was with GlaxoSmithKline for 23 years, where he held several roles including Head, Global Marketing and Senior Vice President of Commercial Development (International). He has been a Director of the Company since January 2010 and Chief Executive Officer since February 2, 2015.
Chief Operating Officer
Manoj holds a Ph.D in pharmaceutical chemistry from the University of Kansas and a degree in business administration from the Wharton School of the University of Pennsylvania. He has over 19 years of experience in formulations. Prior to joining Syngene in 2009, he worked with Novartis Healthcare Private Limited as project manager - TRD.
M. B. Chinappa
Chief Financial Officer
Mr Chinappa holds a bachelors degree in commerce from St. Joseph’s College of Commerce, Bangalore and is a member of the ICAI. He has over 22 years of experience in the field of finance. Prior to joining Syngene in 2008, he worked with Biocon Limited as group Vice president (Finance).
Anita holds a Masters degree in Science and Ph.D from the All India Institute of Medical Sciences and Post Doctoral fellowship from the McMaster’s University in Ontario, Canada in neuropharmacology. She has over 20 years of experience in the field of discovery biology. Prior to joining Syngene in 2011, she worked with Aurigene Discovery Technologies Limited as a Research Director.
K S Rao
Head - Veterinary Sciences
Dr. K. S. Rao (B.V.Sc & A.H., M.V.Sc., Ph.D.,) is a Board Certified Toxicologist with more than 35 years of global experience in safety evaluation - toxicology supporting drug discovery & development, agrochemical research and development and is associated with Syngene since May 2011.
He is Emeritus Member of the Society of Toxicology – SOT in US. He is the first Indian Toxicologist to be appointed for this status for being a member of the SOT for 40 years.
Dr. Rao has led multidisciplinary teams in designing/constructing, maintaining, managing of preclinical research – toxicology & animal breeding/stock facilities (to international standards-guidelines, fulfilling Good Laboratory Practice (GLP) requirements) in USA and India.
Dr. Rao has published papers and presented papers in international seminars. He is a member and actively contributed in international organizations in the field of toxicology. He is the principal author of more than 200 safety evaluation study reports of various new compounds marketed or to be marketed. These reports are submitted to various regulatory authorities of several countries, including, FDA & EPA (U.S.A), European, Japanese Health and Indian Regulatory Authorities.
Head (Pharmaceutical and Biopharmaceutical Development)
Dhananjay holds a Ph.D in Chemincal Engineering from the University of Utah, USA and a Post Doctoral Fellowship at the Department of Chemical and Biochemical Engineering, Rutgers University, USA. He has over 20 years of experience in biotechnology. Prior to joining Syngene in 2010, he worked with Indus Biotherapeutics Limited as Chief Operating Officer.
Dr. Subhash Thuluva
Head - Clinical Development
Subash holds a Masters degree in Science from University of Applied Sciences, Reutlingen University, Germany and a PHD from university of BOWN , Germany. He has over 7 years of experience in the field of clinical development. Prior to joining of Syngene in 2014, he worked with Novartis Healthcare Private Limited as a Group Lead – Global Clinical Operations.
Head (Chemical Development)
Jegadeesh holds a Ph.D in Chemical Technology from Department of Chemical Technology, University Mumbai, post doctoral fellowship from Institute National Polytechnic Toulouse, France and a post graduate diploma in management from the Indian Institute of Management, Kozhikode. He has over 14 years of research and development experience with chemical and catalysis industries. Prior to joining Syngene in 2005, he worked with GE India Technology Centre as a research scientist.
Head - Corporate Quality / Regulatory Compliance
Ajit Simh Joined Syngene in April 2014 bringing 30 plus years of Corporate and Quality leadership to strengthen Syngene’s existing global regulatory compliance platform.
Ajit has been employed in the biotechnology / pharmaceutical industry in the US for 30 plus years after receiving his post-graduate degree in cell biology. His experience with both large and small to mid-size pharmaceutical companies at Mallinckrodt, Inc., Abbott Biotech, Baxter Healthcare and others includes R&D, production, operations and regulatory compliance. Over the years, Ajit has gained an excellent understanding on the global regulatory compliance requirements by the US FDA and ICH bodies for the manufacture and control of small and large molecule API’s and oral and parenteral dosage forms. He has worked with several companies in the US and internationally over the years to prepare them for US and EU inspection readiness. Ajit is active in academia and is an adjunct professor with a dual appointment at the University of California, San Diego and San Diego State University teaching classes in the M.S program in regulatory compliance and advanced quality.
He holds a Masters degree in Pharmacy from the University of Pune and a Ph.D from the Birla Institute of Technology. He has over 20 years of experience in the field of formulation. Prior to joining of Syngene in 2012, he worked with Sandoz Development Center as a Group Head - Galenical.
Company Secretary and Compliance Officer
Mayank holds a Masters degree in Business Administration from Barkatullah Vishwavidyalaya, Bhopal and is a member of the ICSI. He has over 9 years of experience in the field of corporate compliance. Prior to joining Syngene in 2012, he worked with ING Vysya Bank Limited as Assistant Company Secretary.